Implicaciones clínico-diagnósticas del péptido ghrelin
Leído
10461
Vecesse ha leído el artículo
2345
Total PDF
8116
Total HTML
Información del artículo
ISSN: 16954033Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 41 | 13 | 54 |
| 2025 5 | 123 | 36 | 159 |
| 2025 4 | 108 | 35 | 143 |
| 2025 3 | 122 | 23 | 145 |
| 2025 2 | 102 | 29 | 131 |
| 2025 1 | 72 | 23 | 95 |
| 2024 12 | 95 | 29 | 124 |
| 2024 11 | 74 | 57 | 131 |
| 2024 10 | 64 | 31 | 95 |
| 2024 9 | 74 | 24 | 98 |
| 2024 8 | 84 | 59 | 143 |
| 2024 7 | 61 | 36 | 97 |
| 2024 6 | 74 | 25 | 99 |
| 2024 5 | 68 | 24 | 92 |
| 2024 4 | 64 | 36 | 100 |
| 2024 3 | 60 | 36 | 96 |
| 2024 2 | 47 | 35 | 82 |
| 2024 1 | 54 | 23 | 77 |
| 2023 12 | 58 | 19 | 77 |
| 2023 11 | 55 | 19 | 74 |
| 2023 10 | 51 | 39 | 90 |
| 2023 9 | 41 | 20 | 61 |
| 2023 8 | 62 | 23 | 85 |
| 2023 7 | 42 | 25 | 67 |
| 2023 6 | 42 | 34 | 76 |
| 2023 5 | 81 | 22 | 103 |
| 2023 4 | 36 | 15 | 51 |
| 2023 3 | 52 | 33 | 85 |
| 2023 2 | 46 | 22 | 68 |
| 2022 1 | 78 | 18 | 96 |
| 2022 12 | 101 | 30 | 131 |
| 2022 11 | 94 | 50 | 144 |
| 2022 10 | 77 | 36 | 113 |
| 2022 9 | 65 | 34 | 99 |
| 2022 8 | 51 | 42 | 93 |
| 2022 7 | 38 | 43 | 81 |
| 2022 6 | 32 | 33 | 65 |
| 2022 5 | 58 | 39 | 97 |
| 2022 4 | 44 | 50 | 94 |
| 2022 3 | 68 | 51 | 119 |
| 2022 2 | 51 | 29 | 80 |
| 2021 1 | 52 | 44 | 96 |
| 2021 12 | 40 | 34 | 74 |
| 2021 11 | 48 | 40 | 88 |
| 2021 10 | 99 | 57 | 156 |
| 2021 9 | 52 | 33 | 85 |
| 2021 8 | 67 | 31 | 98 |
| 2021 7 | 33 | 34 | 67 |
| 2021 6 | 47 | 28 | 75 |
| 2021 5 | 49 | 26 | 75 |
| 2021 4 | 139 | 81 | 220 |
| 2021 3 | 66 | 19 | 85 |
| 2021 2 | 49 | 16 | 65 |
| 2020 1 | 61 | 21 | 82 |
| 2020 12 | 60 | 15 | 75 |
| 2020 11 | 37 | 9 | 46 |
| 2020 10 | 34 | 17 | 51 |
| 2020 9 | 21 | 10 | 31 |
| 2020 8 | 48 | 10 | 58 |
| 2020 7 | 50 | 12 | 62 |
| 2020 6 | 56 | 14 | 70 |
| 2020 5 | 52 | 12 | 64 |
| 2020 4 | 31 | 8 | 39 |
| 2020 3 | 25 | 19 | 44 |
| 2020 2 | 45 | 13 | 58 |
| 2020 1 | 36 | 11 | 47 |
| 2019 12 | 34 | 14 | 48 |
| 2019 11 | 29 | 6 | 35 |
| 2019 10 | 33 | 18 | 51 |
| 2019 9 | 33 | 10 | 43 |
| 2019 8 | 33 | 18 | 51 |
| 2019 7 | 35 | 26 | 61 |
| 2019 6 | 48 | 17 | 65 |
| 2019 5 | 96 | 47 | 143 |
| 2019 4 | 100 | 43 | 143 |
| 2019 3 | 49 | 11 | 60 |
| 2019 2 | 37 | 11 | 48 |
| 2019 1 | 30 | 19 | 49 |
| 2018 12 | 39 | 18 | 57 |
| 2018 11 | 72 | 22 | 94 |
| 2018 10 | 83 | 23 | 106 |
| 2018 9 | 37 | 8 | 45 |
| 2018 8 | 3 | 0 | 3 |
| 2018 7 | 5 | 0 | 5 |
| 2018 6 | 4 | 0 | 4 |
| 2018 5 | 13 | 0 | 13 |
| 2018 4 | 23 | 0 | 23 |
| 2018 3 | 36 | 0 | 36 |
| 2018 2 | 26 | 0 | 26 |
| 2018 1 | 23 | 0 | 23 |
| 2017 12 | 22 | 0 | 22 |
| 2017 11 | 31 | 0 | 31 |
| 2017 10 | 24 | 0 | 24 |
| 2017 9 | 39 | 0 | 39 |
| 2017 8 | 11 | 0 | 11 |
| 2017 7 | 24 | 0 | 24 |
| 2017 6 | 27 | 13 | 40 |
| 2017 5 | 23 | 8 | 31 |
| 2017 4 | 17 | 4 | 21 |
| 2017 3 | 20 | 3 | 23 |
| 2017 2 | 26 | 2 | 28 |
| 2016 1 | 13 | 5 | 18 |
| 2016 12 | 16 | 3 | 19 |
| 2016 11 | 45 | 6 | 51 |
| 2016 10 | 53 | 14 | 67 |
| 2016 9 | 48 | 8 | 56 |
| 2016 8 | 44 | 9 | 53 |
| 2016 7 | 24 | 5 | 29 |
| 2016 3 | 4 | 0 | 4 |
| 2015 11 | 1 | 0 | 1 |
| 2015 8 | 1 | 0 | 1 |
| 2015 7 | 4 | 0 | 4 |
| 2015 5 | 4 | 0 | 4 |
| 2015 4 | 4 | 0 | 4 |
| 2015 3 | 10 | 0 | 10 |
| 2015 2 | 9 | 0 | 9 |
| 2015 1 | 9 | 1 | 10 |
| 2014 12 | 11 | 0 | 11 |
| 2014 11 | 8 | 3 | 11 |
| 2014 10 | 12 | 1 | 13 |
| 2014 9 | 11 | 3 | 14 |
| 2014 8 | 12 | 2 | 14 |
| 2014 7 | 16 | 2 | 18 |
| 2014 6 | 32 | 2 | 34 |
| 2014 5 | 32 | 2 | 34 |
| 2014 4 | 26 | 3 | 29 |
| 2014 3 | 21 | 1 | 22 |
| 2014 2 | 22 | 3 | 25 |
| 2014 1 | 23 | 1 | 24 |
| 2013 12 | 27 | 1 | 28 |
| 2013 11 | 25 | 3 | 28 |
| 2013 10 | 25 | 4 | 29 |
| 2013 9 | 26 | 3 | 29 |
| 2013 8 | 27 | 3 | 30 |
| 2013 7 | 20 | 2 | 22 |
| 2004 5 | 2259 | 0 | 2259 |
Mostrar todo
